These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21948603)

  • 41. Lipid levels after acute coronary syndromes.
    Pitt B; Loscalzo J; Ycas J; Raichlen JS
    J Am Coll Cardiol; 2008 Apr; 51(15):1440-5. PubMed ID: 18402897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study.
    O'Neil-Callahan K; Katsimaglis G; Tepper MR; Ryan J; Mosby C; Ioannidis JP; Danias PG
    J Am Coll Cardiol; 2005 Feb; 45(3):336-42. PubMed ID: 15680709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Real-life use of the polypill components (ASA+ACEI+statins) after an acute coronary syndrome and long-term mortality.
    Oliveras Vilà T; Ferrer Massot M; Curós Abadal A; Rueda Sobella F; Serra Flores J; Carrillo Suárez X; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):209-10. PubMed ID: 25499380
    [No Abstract]   [Full Text] [Related]  

  • 44. Early statin therapy in patients with acute coronary syndrome.
    Liberopoulos EN; Daskalopoulou SS; Mikhailidis DP
    Hellenic J Cardiol; 2005; 46(1):5-8. PubMed ID: 15807388
    [No Abstract]   [Full Text] [Related]  

  • 45. Aggressive statin therapy for acute coronary syndromes.
    Vun Liew T; Ray KK
    Curr Cardiol Rep; 2007 Jul; 9(4):298-302. PubMed ID: 17601396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Triglycerides and cardiovascular events in ACS: the need for combined lipid-altering therapies.
    Rosenson RS; Pitt B
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):98-100. PubMed ID: 19079366
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese.
    Sakamoto T; Kojima S; Ogawa H; Shimomura H; Kimura K; Ogata Y; Sakaino N; Kitagawa A;
    Am J Cardiol; 2006 Apr; 97(8):1165-71. PubMed ID: 16616020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CETP inhibition shows promise as way to reduce cardiovascular disease risk.
    Mitka M
    JAMA; 2011 Jan; 305(2):136-7. PubMed ID: 21224449
    [No Abstract]   [Full Text] [Related]  

  • 49. Is there a true beneficial effect of statin therapy in the acute phase of unstable angina or myocardial infarction?
    Correia LC
    Curr Vasc Pharmacol; 2007 Jul; 5(3):221-5. PubMed ID: 17627565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationships between chronic use of statin therapy, presentation of acute coronary syndromes and one-year mortality after an incident acute coronary event.
    Vervueren PL; Elbaz M; Dallongeville J; Arveiler D; Ruidavets JB; Montaye M; Wagner A; Amouyel P; Haas B; Bongard V; Ferrières J
    Int J Cardiol; 2013 Feb; 163(1):102-4. PubMed ID: 22790192
    [No Abstract]   [Full Text] [Related]  

  • 51. [Acute coronary syndrome in patients with carbohydrate metabolic disturbances (a review)].
    Kremneva LV; Shalaev SV
    Ter Arkh; 2009; 81(10):27-34. PubMed ID: 19947437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Addition of statins into the public water supply? Risks of side effects and low cholesterol levels].
    Ginter E; Kajaba I; Sauša M
    Cas Lek Cesk; 2012; 151(5):243-7. PubMed ID: 22779765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The invasive approach to acute coronary syndrome: true promise or false premise?
    Thompson PL
    Med J Aust; 2010 Jun; 192(12):694-5. PubMed ID: 20565347
    [No Abstract]   [Full Text] [Related]  

  • 54. Statin therapy in primary CVD prevention remains a hot-button topic for some.
    Mitka M
    JAMA; 2011 Nov; 306(19):2077-8. PubMed ID: 22089707
    [No Abstract]   [Full Text] [Related]  

  • 55. Cochrane review questions evidence for statins for primary prevention in low risk groups.
    Mayor S
    BMJ; 2011 Jan; 342():d480. PubMed ID: 21262902
    [No Abstract]   [Full Text] [Related]  

  • 56. [Controversies regarding the use of statins in the acute coronary syndrome].
    Camps D
    Med Intensiva; 2010; 34(6):432; author reply 432-3. PubMed ID: 20538377
    [No Abstract]   [Full Text] [Related]  

  • 57. Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.
    Lee MMY; Sattar N; McMurray JJV; Packard CJ
    Curr Atheroscler Rep; 2019 Jul; 21(10):41. PubMed ID: 31350612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heart failure and statins--why do we need a clinical trial?
    Böhm M; Hjalmarson A; Kjekshus J; Laufs U; McMurray J; van Veldhuisen DJ
    Z Kardiol; 2005 Apr; 94(4):223-30. PubMed ID: 15803258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensive LDL Reduction Post Acute Coronary Syndromes: A Catalyst for Improved Outcomes.
    Kostner K; Nicholls S; Amerena J; Brown A; Cooper M; Hammett C; O'Brien R; Kritharides L; Hare DL; Watts GF; Aylward P; Kostner K; Nicholls S; Amerena J; Brown A; Cooper M; Hammett C; O'Brien R; Kritharides L; Hare DL; Watts GF; Aylward P
    Heart Lung Circ; 2016 Nov; 25(11):1051-1054. PubMed ID: 27725093
    [No Abstract]   [Full Text] [Related]  

  • 60. Statin therapy in acute cardiovascular syndromes.
    Jialal I; Devaraj S
    Curr Opin Lipidol; 2007 Oct; 18(5):610-2. PubMed ID: 17885436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.